Growth markets Oncovision operates with a global reach across 30+ markets through direct sales and distributors, presenting multiple expansion opportunities in new and developing regions for advanced cancer imaging devices.

Clinical leadership A diversified product portfolio including Sentinella intra-operative Gamma Camera, MAMMI PET, Wprobe, and Albira positions the company to address surgical, diagnostic, and preclinical needs, enabling cross-sell across oncology workflows.

High-value differentiation Cutting-edge imaging capabilities that visualize submillimeter lesions and quantify tumor activity offer compelling value propositions for hospitals and cancer centers seeking precision diagnostics and improved surgical outcomes.

Strategic partnerships Presence in Boston and Valencia paired with distributors suggests potential channel partnerships, regional biennial trade shows, and integrator collaborations to accelerate adoption in key markets.

Growth funding signals Recent funding of ten million dollars alongside a modest revenue base indicates available capital for sales expansion, aftermarket services, training programs, and service contracts to drive renewals and upsell opportunities.